European Patients Forum, logo.

New webinar series: Amplifying patient advocacy on Antimicrobial Resistance (AMR)

Antimicrobial Resistance (AMR) presents a significant global health threat across diverse sectors, including in humans, animals, plants, food, and the environment.

The multisectoral approach to addressing AMR in these sectors is termed One Health. In 2019, the Global Research on Antimicrobial Resistance (GRAM) report found that 1.27 million deaths were directly attributed to bacterial AMR alone.

The European Patients’ Forum (EPF) and The AMR Narrative are organising a webinar series to create an exchange space for diverse groups of patients, carers, survivors and civil society organisations impacted by AMR who want to advance advocacy efforts. This series will aim to discuss how to empower patients to shape and share their own stories and advocate for ambitious policy action in this crucial area of global health sustainability and security.

  • Webinar 1: Patient Advocacy on AMR in the EU: where do we begin? - 20 June 2024, 3 - 4pm CEST
  • Webinar 2: How do we use our voices to reach a wider community for AMR? - August 2024 (more details soon)
  • Webinar 3: How can we take AMR advocacy to the next level, including policymaking? - September 2024 (more details soon), as a lead up to the UNGA HLM 2024

Register here.

The first webinar in June will bring together patient representatives and AMR experts, and will answer the following questions:

  • How are patient communities impacted by AMR?
  • What interventions or ideas could be used to boost patient advocacy on AMR?
  • What are the biggest challenges towards improving advocacy and understanding of AMR?

Agenda and speakers:

  • Introduction and welcome remarks
    • Speakers: Francesca Chiara (Chair of the Board of Trustees, The AMR Narrative) and Claudia Louati (Head of Policy, EPF)
  • Overview of AMR: What is it and where do we stand now in the EU?
    • Speaker: Dominique Monnet (Head of Section AMR and HAI, European Centre for Disease Prevention and Control - ECDC)
  • Story from a patient survivor
    • Video message from Ella Balasa (Cystic Fibrosis and AMR survivor)
  • Panel discussion and Q&A: Reaching out to diverse patient populations (moderated by Claudia Louati, EPF)
    • Speakers: Vanessa Carter (Executive Director of the AMR Narrative and Chair of the WHO Task Force of AMR Survivors)
    • Mary Lynne Van Poelgeest-Pomfret (President of World Federation of Incontinence and Pelvic Problems)
    • Gavin Schranz (WHO Europe Youth4Health Network Member)
  • Closing
    • Francesca Chiara (The AMR Narrative)

Register here.

This will be an open webinar series targeting patients, patient groups, civil society organisations (CSOs), third sector groups in Europe and globally, as well as health professionals and others working in the field of AMR.

All webinars will be held in English via Zoom and recordings will be made available.

Notes:

AMR in Europe: https://www.who.int/europe/news/item/26-01-2022-who-ecdc-report-antimicrobial-resistance-remains-threat-to-health-in-european-region

AMR globally: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02724-0/fulltext